Soft Tissue Infection
📧 Sign up to get email alerts when something new happens for Soft Tissue Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: FATAL-NSTI Study (Factors Associated With In-hospital mortALity in NSTI).
The FATAL-NSTI study, sponsored by the University of Cagliari, is currently recruiting to identify factors associated with in-hospital morta…
-
EMA approval · 2026-01-20EMA Authorised: Daptomycin Hospira (daptomycin) — Pfizer Europe MA EEIG
The EMA authorised Daptomycin Hospira (daptomycin) for marketing in the EU for soft tissue infections and bacterial skin infections, with de…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Discharge Stewardship in Children's Hospitals [NA]
A pediatric discharge stewardship trial update from the Children's Hospital of Philadelphia states the study is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial [NA]
Clinical trial FAAN-C is comparing automatic versus as-needed follow-up, and the study is currently recruiting at the University of Utah for…
-
EMA approval · 2025-11-14EMA Authorised: Zavicefta (avibactam sodium;ceftazidime pentahydrate) — Pfizer Ireland Pharmaceuticals Unlimited Company
The EMA authorised Zavicefta (avibactam sodium and ceftazidime pentahydrate) for treatment of pneumonia, soft tissue infections, urinary tra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-11-07EMA Authorised: Cubicin (daptomycin)
The European Medicines Agency authorised Cubicin (daptomycin) for Gram-positive bacterial infections including bacteremia, soft tissue infec…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Necrotizing Soft Tissue Infections
The document reports an ongoing clinical trial enrollment by invitation for necrotizing soft tissue infections, including Fournier gangrene,…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) for Invasive Infections Related to Opioid Use [Phase 4]
Phase 4 trial evaluating anchoring sequential intermittent long-acting antimicrobials with medication-assisted treatment for opioid use diso…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine (GSK3878858A) When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI) [Phase 2]
Phase 2 trial assessing safety, immunogenicity, and efficacy of the GSK3878858A Staphylococcus aureus vaccine in healthy adults and in adult…
-
EMA approval · 2024-11-20EMA Authorised: Tenkasi (previously Orbactiv) (oritavancin (diphosphate)) — Menarini International Operations Luxembourg S.A.
The European Medicines Agency has authorised Tenkasi (oritavancin diphosphate) by Menarini International Operations Luxembourg S.A. for soft…
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: Comparative Effectiveness of Emergency Ultrasound Guided Management of Pediatric Soft Tissue Infections
This entry notes the completion of a clinical trial comparing emergency ultrasound-guided management of pediatric soft tissue infections.
-
EMA withdrawal · 2017-10-10EMA Application withdrawn: Tigecycline Accord (tigecycline) — Accord Healthcare Ltd
The EMA withdrew the application for Tigecycline Accord by Accord Healthcare Ltd for soft tissue infections.
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036) [Phase 2]
Phase 2 study of ertapenem in pediatric patients with urinary tract infections, pneumonia, and soft tissue infections completed.
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Diabetic Foot Ulcer. Effectiveness of Chlorhexidine Gluconate 0.125 % Compared With Sterile Deionized Water [Phase 4]
Phase 4 trial evaluating chlorhexidine gluconate 0.125% versus sterile deionized water for diabetic foot ulcers has completed. The sponsor i…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection [Phase 4]
Phase 4 trial update on twice-daily application of Altabax for uncomplicated soft tissue infections, including impetigo and folliculitis, wi…
-
CLINICAL_TRIALS trial_result · 2011-08-09Clinical Trial Update: Target Site Pharmacokinetics of Ertapenem After Multiple Doses in Diabetes Patients With Soft Tissue Infection [Phase 4]
Phase 4 study update on the site pharmacokinetics of ertapenem after multiple doses in diabetes patients with soft tissue infection; the tri…